These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 20181277

  • 1. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, Sharpe O, Roscow C, Ho PP, Lee DM, Robinson WH.
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [Abstract] [Full Text] [Related]

  • 2. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
    Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, Utz PJ, Steinman L, Robinson WH.
    J Clin Invest; 2006 Oct; 116(10):2633-42. PubMed ID: 16981009
    [Abstract] [Full Text] [Related]

  • 3. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.
    Garcia S, Hartkamp LM, Malvar-Fernandez B, van Es IE, Lin H, Wong J, Long L, Zanghi JA, Rankin AL, Masteller EL, Wong BR, Radstake TR, Tak PP, Reedquist KA.
    Arthritis Res Ther; 2016 Mar 31; 18():75. PubMed ID: 27036883
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.
    Dewar AL, Domaschenz RM, Doherty KV, Hughes TP, Lyons AB.
    Leukemia; 2003 Sep 31; 17(9):1713-21. PubMed ID: 12970769
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.
    Kim SJ, Chen Z, Chamberlain ND, Essani AB, Volin MV, Amin MA, Volkov S, Gravallese EM, Arami S, Swedler W, Lane NE, Mehta A, Sweiss N, Shahrara S.
    J Immunol; 2014 Oct 15; 193(8):3902-13. PubMed ID: 25200955
    [Abstract] [Full Text] [Related]

  • 11. Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice.
    Koyama K, Hatsushika K, Ando T, Sakuma M, Wako M, Kato R, Haro H, Sugiyama H, Hamada Y, Ogawa H, Nakao A.
    Mod Rheumatol; 2007 Oct 15; 17(4):306-10. PubMed ID: 17694264
    [Abstract] [Full Text] [Related]

  • 12. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W, Zhang Y, Zhu W, Ma C, Ruan J, Long H, Wang Y.
    Front Immunol; 2018 Oct 15; 9():2228. PubMed ID: 30319663
    [Abstract] [Full Text] [Related]

  • 13. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
    Crespo O, Kang SC, Daneman R, Lindstrom TM, Ho PP, Sobel RA, Steinman L, Robinson WH.
    J Clin Immunol; 2011 Dec 15; 31(6):1010-20. PubMed ID: 21847523
    [Abstract] [Full Text] [Related]

  • 14. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.
    Kabala PA, Malvar-Fernández B, Lopes AP, Carvalheiro T, Hartgring SAY, Tang MW, Conde C, Baeten DL, Sleeman M, Tak PP, Connor J, Radstake TR, Reedquist KA, García S.
    Rheumatology (Oxford); 2020 Feb 01; 59(2):426-438. PubMed ID: 31377797
    [Abstract] [Full Text] [Related]

  • 15. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
    Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Umeda N, Tanaka Y, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.
    Mod Rheumatol; 2011 Jun 01; 21(3):267-75. PubMed ID: 21188449
    [Abstract] [Full Text] [Related]

  • 16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Jun 01; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 17. JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor.
    Uesato N, Inagaki K, Miyagawa N, Kitagawa Y, Kakefuda R, Matsuo Y, Yamaguchi T, Hata T, Ikegashira K, Matsushita M.
    Biol Pharm Bull; 2020 Jun 01; 43(12):1884-1892. PubMed ID: 33268706
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
    Conway JG, McDonald B, Parham J, Keith B, Rusnak DW, Shaw E, Jansen M, Lin P, Payne A, Crosby RM, Johnson JH, Frick L, Lin MH, Depee S, Tadepalli S, Votta B, James I, Fuller K, Chambers TJ, Kull FC, Chamberlain SD, Hutchins JT.
    Proc Natl Acad Sci U S A; 2005 Nov 01; 102(44):16078-83. PubMed ID: 16249345
    [Abstract] [Full Text] [Related]

  • 19. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.
    Chang BY, Huang MM, Francesco M, Chen J, Sokolove J, Magadala P, Robinson WH, Buggy JJ.
    Arthritis Res Ther; 2011 Jul 13; 13(4):R115. PubMed ID: 21752263
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.